Jotin Marango

CIK: 0001777513

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMA

ImageneBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

IMA
ImageneBio, Inc.
Jul 28, 2025
Award(A)
Direct
15.8K shares-
IMA
ImageneBio, Inc.
Jul 28, 2025
Tax Payment(F)
Direct
4.6K shares at avg. $17.16$79K
IMA
ImageneBio, Inc.
Jul 25, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
181K shares-
IMA
ImageneBio, Inc.
Jul 25, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
105K shares-
IMA
ImageneBio, Inc.
Jul 25, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
397.2K shares-

		Type	Shares	Price		Ownership
Jul 28, 2025	IMA ImageneBio, Inc.	Award(A)	15,776	-	-	Direct
Jul 28, 2025	IMA ImageneBio, Inc.	Tax Payment(F)	4,630	$17.16	$79,451	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Disposition(D) Stock Option (Right to Buy)	181,000	-	-	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Disposition(D) Stock Option (Right to Buy)	105,000	-	-	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Disposition(D) Stock Option (Right to Buy)	397,199	-	-	Direct

1-5 of 5 transactions

About Marango Jotin

Marango Jotin (SEC CIK 0001777513) files insider reports with the SEC as Chief Financial Officer of ImageneBio, Inc. (IMA).

Signal8 holds 1 ownership filing by Marango Jotin, a Form 4, filed on Jul 29, 2025. Those filings report 5 transactions, from Jul 25, 2025 to Jul 28, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Marango Jotin's filings is in BOSTON, MA.

Recent filings by Marango Jotin

Jul 28, 2025: Grant or award of IMA shares (Form 4, code A).
Jul 28, 2025: Tax withholding of IMA shares (Form 4, code F).
Jul 25, 2025: Disposition to issuer transactions of IMA derivative securities (3 lines, Form 4, code D).

Other insiders filing for ImageneBio, Inc. (IMA)

Yarema Kristin, Chief Executive Officer
Grant-Huerta Yanina, Chief Financial Officer
Lally Robert B, Principal Accounting Officer
Wang Jonathan Jian, Director
Stampacchia Otello, Director
SLATTERY JOSEPH P, Director

How to read Form 4 transaction codes